WESTON, Mass. — The Food and Drug Administration has approved two separate dosing innovations for multiple sclerosis patients that are being treated with a Biogen Idec drug. Biogen Idec said the FDA ...
LOS ANGELES, Sept 15 (Reuters) - Biogen Idec has been issued a U.S. patent for the use of beta interferon for treating viral conditions and diseases, cancers or tumors, the company said in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback